Filed before 2025Filed 30 April 2021
Lengo Therapeutics, Inc. has sold $17.7M so far
Lengo Therapeutics, Inc., a pharmaceuticals company based in Menlo Park, CA, has sold $17.7M so far in its equity round, according to a filing dated 30 April 2021.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 30 April 2021
- First filed
- 9 April 2020
- Round
- Equity round (amended filing)
- Amount sold
- $17.7M
- Offering size
- $17.7M
- Investors so far
- 4
- Based in
- Menlo Park, CA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 61% of the 2,220 tracked raises with an amount filed in 2021, and than 50% of the 40 in pharmaceuticals.
Lengo Therapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 30 Apr 2021 | Amended filing | $17.7M | This raise |
More with Indiana on the board
- Nature's Toolbox, Inc.$10.4M
- Sudo Biosciences, Inc.$63.6M
- Gilson Snow, Inc.$953K
- Aura Biosciences, Inc.$80.5M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.